You are here:

Big cannabis in the UK: is industry support for wider patient access motivated by promises

posted 18/03/2020

publication BMJ 2020;368:m1002 doi: 10.1136/bmj.m1002 (Published 18 March 2020)

Big in the UK: is industry support for wider patient access motivated by promises of recreational market worth billions?

The BMJ has uncovered links between companies, campaign groups, and individuals lobbying forwider patient access to cannabis for medical use and a parallel campaign to create a lucrative
recreational market for the drug in the UK, Jonathan Gornall reports

get involved

If you are interested in what we do and would like to support our work, find out more ways to get involved.

Donate

get our book

Drugs: It’s just not worth it

Drugs: It’s just not worth it

Our 35-page book gives clear and easy to read facts and advice aimed at teenagers and young people.

£3.00

Buy Now